
Academic Journal
Q1European Urology Open Science
About European Urology Open Science
European Urology Open Science is a scholarly journal published by Elsevier B.V.. SCImago 2025 lists it in Q1, with an SJR of 1.587 and H-index of 44.
Coverage: 2020-2026. Research categories: Urology (Q1).
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-04-27. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Prostate Cancer Diagnosis and Treatment; Bladder and Urothelial Cancer Treatments; Prostate Cancer Treatment and Research; Renal cell carcinoma treatment; Urological Disorders and Treatments; Urinary Bladder and Prostate Research.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Re: Nielsen N.K, Hjort P.B, Hansen E.B, et al. Substaging and stratified treatment of T1 bladder cancer – a nationwide register‑based study. Eur Urol Open Sci 2026;90:92‑100
Xin Li, Yapeng Xing
2026-11 · DOI: 10.1016/j.euros.2026.08.008Global Direct In-scope Suction Study: An EAU-endourology Multicenter Prospective Collaboration (DISS-study)
Vineet Gauhar, Daniele Castellani, Olivier Traxer, Deepak Ragoori et al.
2026-11 · DOI: 10.1016/j.euros.2026.09.004PRECISE Assessment of Sequential Biparametric MRI and Clinically Significant Prostate Cancer in Biopsy-naive Men: A Retrospective Cohort Study
Yuxuan Tian, Zhijian Liu, Shuyuan Chen, Yuxi Zhou et al.
2026-11 · DOI: 10.1016/j.euros.2026.09.002PSMA PET/CT Kinetics During Systemic Therapy and Radiotherapy in Hormone-sensitive Prostate Cancer: A Systematic Review
Jennifer Le Guévelou, Matteo Bauckneht, Timo F.W. Soeterik, Matthijs Scheltema et al.
2026-11 · DOI: 10.1016/j.euros.2026.09.003Incisional Hernia After Minimally Invasive Radical Prostatectomy: A Systematic Review
Arthur Peyrottes, Olivier Oberlin, Michael Baboudjian, Charles Dariane et al.
2026-11 · DOI: 10.1016/j.euros.2026.08.002Reply to Drs. Bayraktar and İşler's Letter to the Editor re: Basadonna LM, Passarelli F, Graps G, et al. Music During Transperineal Prostate Biopsy (The VIVALDI Trial): A Few Questions on the Gap Between Self-reported Benefit and Objective Findings
Ludovico Maria Basadonna, Elisa De Lorenzis, Giancarlo Albo, Luca Boeri et al.
2026-11 · DOI: 10.1016/j.euros.2026.09.001Ex Vivo Microtumor Testing to Predict Chemotherapy Responses in Patients with Bladder Cancer
Mathijs P. Scholtes, Esmee Koedoot, Lieke J. Ceton, Timothy J.P. Sijsenaar et al.
2026-11 · DOI: 10.1016/j.euros.2026.07.009Reply to Singh and Srivastav’s Letter to the Editor re: Marc A. Furrer, Benjamin Lyttwin, Michael S. Pärli, et al. Incidental Prostate Cancer Is an Uncommon but Clinically Non-negligible Cause of Death in Selected Long-term Survivors of Urothelial Carcinoma: Oncological Outcomes and a Proposed Follow-up Strategy from a Tertiary Referral Center. Eur Urol Open Sci 2026;86:10–19
Marc A. Furrer, Patrick Y. Wuethrich, Niall M. Corcoran
2026-10 · DOI: 10.1016/j.euros.2026.05.001Ice Water Test Unmasks Detrusor Overactivity in Apparently Normal Conventional Cystometry
Lara Stächele, Helen Sadri, Collene E. Anderson, Veronika Birkhäuser et al.
2026-10 · DOI: 10.1016/j.euros.2026.08.004Contents
2026-10 · DOI: 10.1016/s2666-1683(26)01840-9Cost-utility of NeuroSAFE-guided RARP Versus Standard RARP in Men with Localised Prostate Cancer in the UK
Jiunn Wang, Ricardo Almeida–Magana, Eoin Dinneen, Shengning Pan et al.
2026-10 · DOI: 10.1016/j.euros.2026.08.007Longitudinal Economic Burden for Non–Muscle-Invasive Bladder Cancer by EAU Progression Risk Groups Using the Prospective Multicenter COBLAnCE Cohort Linked to the French National Healthcare System Database
Aldéric M. Fraslin, Simone Benhamou, Thierry Lebret, Yann Neuzillet et al.
2026-10 · DOI: 10.1016/j.euros.2026.08.005Comparative Assessment of METastasis Reporting and Data System for Prostate Cancer Versus Prostate Cancer Clinical Trials Working Group 3 Criteria in Assessing Treatment Response in Patients with Metastatic Castration-resistant Prostate Cancer
Luca Russo, Ossian Longoria, Silvia Bottazzi, Nuria Porta et al.
2026-10 · DOI: 10.1016/j.euros.2026.08.003An Updated Systematic Review, Meta-analysis, and Trial Sequential Analysis of Endoscopic Combined Intrarenal Surgery (ECIRS) versus Percutaneous Nephrolithotomy (PCNL) for Upper Urinary Tract Calculi
Bruno D. Terada, Artur S. Almeida, Felipe G.A. Gonçalves, Leonardo O.D. da Silva et al.
2026-10 · DOI: 10.1016/j.euros.2026.07.005Editorial Board
2026-10 · DOI: 10.1016/s2666-1683(26)01839-2Corrigendum to “Effect of Conventional Versus Flexible and Navigable Suction Ureteral Access Sheaths on Ureteral Temperature Modulation During High-power Ho:YAG Laser Lithotripsy: An In Vitro Evaluation” [Eur. Urol. Open Sci. 84 (2026) 62–69]
Yueqi Huang, Shusheng Liu, Steffi Kar Kei Yuen, Vineet Gauhar et al.
2026-10 · DOI: 10.1016/j.euros.2026.01.017Circulating Plasma and Urine Tumor DNA in Non–muscle-invasive Bladder Cancer: A Promising Biomarker to Guide Therapeutic Intensification
Pierre-Etienne Gabriel, Gautier Marcq, Alec Zhu, John P. Sfakianos et al.
2026-10 · DOI: 10.1016/j.euros.2026.02.003Electrical Pudendal Nerve Stimulation as an Initial Neuromodulation Strategy for Neurogenic Urinary Retention
Tian Li, Jiayi Xu, Siyou Wang, Jianwei Lv et al.
2026-10 · DOI: 10.1016/j.euros.2026.07.008Fungal Urinary Tract Infection: A Brief Manual for Diagnosis and Treatment for Urologists
Kathrin Bausch, Emma J. Smith, Tommaso Cai, Wout Devlies et al.
2026-10 · DOI: 10.1016/j.euros.2026.08.006Re: Marc A. Furrer, Benjamin Lyttwin, Michael S. Pärli, et al. Incidental Prostate Cancer Is an Uncommon but Clinically Non-negligible Cause of Death in Selected Long-term Survivors of Urothelial Carcinoma: Oncological Outcomes and a Proposed Follow-up Strategy from a Tertiary Referral Center. Eur Urol Open Sci 2026;86:10–19
Neeraj Singh, Monika Srivastav
2026-10 · DOI: 10.1016/j.euros.2026.04.012Reviews
Community Reviews
Version History
October 4, 2026 at 8:51 pm
September 25, 2026